Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Lichfield Science and Engineering Society
1 Oct 2015 → 1 Oct 2017
CYTOX LIMITED
1 Dec 2006 → 31 May 2017
Fingerprint
Dive into the research topics where Zsuzsanna Nagy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A low molecular weight dextran sulphate, ILB ®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial
Srinivasan, V., Homer, V., Barton, D., Clutterbuck-James, A., Jenkins, S., Potter, C., Brock, K., Logan, A., Smith, D., Bruce, L., Nagy, Z. & Bach, S. P., 11 Jul 2024, In: PLoS ONE. 19, 7, 24 p., e0291285.Research output: Contribution to journal › Article › peer-review
Open AccessFile24 Downloads (Pure) -
A modified Angoff B screening method for collusion detection in examinations delivered on the MSCAA and Speedwell platforms
Brain, K. & Nagy, Z., 19 Oct 2023, In: The Clinical Teacher. 20, S1, p. 85-86 2 p.Research output: Contribution to journal › Abstract › peer-review
-
A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for amyotrophic lateral sclerosis
Logan, A., Nagy, Z., Barnes, N., Belli, T., Di Pietro, V., Tavazzi, B., Lazzarino, G., Lazzarino, G., Bruce, L. & Persson, L. I., 25 May 2022, In: PLOS One. 17, 5, 21 p., e0267183.Research output: Contribution to journal › Article › peer-review
Open AccessFile90 Downloads (Pure) -
ILB®, a low molecular weight dextran sulphate, restores glutamate homeostasis, amino acid metabolism and neurocognitive functions in a rat model of severe traumatic brain injury
Lazzarino, G., Di Pietro, V., Rinaudo, M., Nagy, Z., Barnes, N., Bruce, L., Signoretti, S., Mangione, R., Saab, M. W., Tavazzi, B., Belli, T., Lazzarino, G., Amorini, A. M. & Logan, A., 30 Jul 2022, In: International Journal of Molecular Sciences. 23, 15, 19 p., 8460.Research output: Contribution to journal › Article › peer-review
Open AccessFile52 Downloads (Pure) -
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: new platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
Logan, A., Belli, T., Di Pietro, V., Tavazzi, B., Lazzarino, G., Mangione, R., Lazzarino, G., Morano, I., Qureshi, O., Bruce, L., Barnes, N. & Nagy, Z., 30 Aug 2022, In: Frontiers in Pharmacology. 13, 19 p., 13:983853.Research output: Contribution to journal › Article › peer-review
Open AccessFile81 Downloads (Pure)
-
Development of a novel repurposed drug treatment for neurodegeneration and diabetes in Wolfram syndrome
Nagy, Z., Peet, A., Brock, K., Barrett, T. & Martin, U.
1/03/17 → 28/02/25
Project: Research Councils
-
CiC: Analysical and clinical validation of an ELISA for the cancer biomarker CLEC14A
Nagy, Z. & Bicknell, R.
CELL THERAPY CATAPULT LIMITED, Medical Research Council
18/02/19 → 31/12/20
Project: Research
-
Accelerating Clinical trials in Wolfram syndrome
Brock, K., Nagy, Z., Calvert, M., Slade, A. & Barrett, T.
EYE HOPE FOUNDATION, ASSOCIATION DU SYNDROME DE WOLFRAM, SNOW FOUNDATION
1/10/17 → 30/09/19
Project: Research
-
-
Preclinical studies with CLEC14A-specific CARs (Catapult) (Chimeric)
Bicknell, R., Lee, S. & Nagy, Z.
1/02/16 → 30/11/19
Project: Industry